The Indian patent, granted in a pharmaceutical market estimated at US $55 billion (Bain & Company) complements Innocan's global patent applications, strengthening the proprietary value of its ...

Pharmaceutical manufacturing encompasses all processes involved in the manufacturing and production of biological and medical products, botanical drugs, and herbs, as well as other pharmaceutical ...

The BLU-U Model 4170E offers a compact, easy-to-use option with the same BLU-U safety and efficacy healthcare professionals have trusted for years. The new LED BLU-U is approved for the same ...

The approval of LED BLU-U was granted under FDA's Real-Time Review Program, reflecting the robustness of the submission and Sun Pharma's continued collaboration with the Agency. The LED BLU-U will ...

The Company reported advancing its efforts to strengthen the protection of its intellectual property across additional Asian markets, following the recently granted patent in India for a ...

TME Pharma secures binding commitments for €1.7M proceeds from regular bonds repayable in cash during 12-month maturity period The transaction extends financial visibility into May 2026 with the ...

For each €0.10 of cash received one private non-tradable warrant to purchase one share, subject to the adjustment below, will be issued with an exercise price of €0.10. Maturity of the ...

BERLIN--(BUSINESS WIRE)--Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by ...

The Company is hereby clarifying and providing additional information on the financing announced on May 21, 2025 TME Pharma has secured private binding commitments from professional European ...

"We are pleased to receive the FDA's approval of LED BLU-U and look forward to seeing the positive impact this next generation device will have for those living with actinic keratosis," said Abhay ...

Medicus Pharma Ltd. One First Canadian Place 100 King Street West Suite 3400 Toronto, Ontario M5X 1A4 Phone 1 732 300-3046 Industry Biotechnology Sector Health Care/Life Sciences Fiscal Year-end ...